2/9
08:21 am
ngen
NervGen Pharma appoints new president & CEO [Seeking Alpha]
Low
Report
NervGen Pharma appoints new president & CEO [Seeking Alpha]
2/9
07:00 am
ngen
NervGen Pharma Appoints Adam Rogers as Chief Executive Officer to Continue Leading the Company’s Growth and Execution of Its Mission in Spinal Cord Injury
Low
Report
NervGen Pharma Appoints Adam Rogers as Chief Executive Officer to Continue Leading the Company’s Growth and Execution of Its Mission in Spinal Cord Injury
1/20
07:28 am
ngen
NervGen Pharma to Ring the Nasdaq Closing Bell on January 22, 2026, Celebrating Its Recent Nasdaq Listing [Canadian Business Journal (Canada)]
Low
Report
NervGen Pharma to Ring the Nasdaq Closing Bell on January 22, 2026, Celebrating Its Recent Nasdaq Listing [Canadian Business Journal (Canada)]
1/20
07:00 am
ngen
NervGen Pharma to Ring the Nasdaq Closing Bell on January 22, 2026, Celebrating Its Recent Nasdaq Listing
Medium
Report
NervGen Pharma to Ring the Nasdaq Closing Bell on January 22, 2026, Celebrating Its Recent Nasdaq Listing
1/8
06:30 am
ngen
NervGen Pharma Begins Trading on Nasdaq Today
High
Report
NervGen Pharma Begins Trading on Nasdaq Today